Trial intelligence / Profile preview

Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

NCT00000570Phase 3Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Jan 1986
Modality
Biologic
01

Overview

A Phase 3 trial of bovactant in respiratory distress syndrome (RDS), sponsored by National Heart, Lung, and Blood Institute. Started Jan 1986; status: completed.

02

Drugs

bovactant
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on NCT00000570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call